|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,809.30 INR | -1.86% |
|
-1.45% | +32.60% |
| Market Cap | 343B 3.59B 3.14B 2.9B 2.68B 5.09B 5.18B 34.77B 13.53B 168B 13.48B 13.19B 584B | P/E 2026 |
32.7x | P/E 2027 * | 29.8x |
|---|---|---|---|---|---|
| Enterprise Value | 350B 3.66B 3.2B 2.96B 2.73B 5.19B 5.28B 35.45B 13.79B 172B 13.75B 13.45B 595B | EV / Sales 2026 |
3.33x | EV / Sales 2027 * | 3.33x |
| Free-Float |
18.3% | Yield 2026 |
0.23% | Yield 2027 * | 0.21% |
Last Transcript: Emcure Pharmaceuticals Limited
| 1 day | -1.86% | ||
| 1 week | -1.45% | ||
| Current month | -1.45% | ||
| 1 month | +2.99% | ||
| 3 months | +16.36% | ||
| 6 months | +18.47% | ||
| Current year | +32.60% |
| 1 week | 1,789.8 | 1,864.8 | |
| 1 month | 1,679 | 1,944 | |
| Current year | 1,381 | 1,944 | |
| 1 year | 1,237 | 1,944 | |
| 3 years | 889 | 1,944 | |
| 5 years | 889 | 1,944 | |
| 10 years | 889 | 1,944 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 1981-04-15 | |
| Director of Finance/CFO | - | 2003-09-30 | |
| Compliance Officer | - | 2026-02-03 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 2001-07-22 | |
| Chairman | 69 | - | |
| Director/Board Member | 75 | 1981-04-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.86% | -1.45% | +45.55% | - | 3.68B | ||
| -1.60% | +1.37% | +57.31% | +168.94% | 1,102B | ||
| -1.44% | +3.71% | +69.64% | +65.40% | 643B | ||
| -0.75% | +0.44% | +34.70% | +86.52% | 450B | ||
| -1.35% | +0.63% | +30.26% | +26.28% | 336B | ||
| -0.86% | +0.99% | +39.36% | +40.85% | 298B | ||
| -0.71% | -0.54% | +28.98% | +48.27% | 288B | ||
| -1.31% | +2.72% | -26.76% | -39.82% | 222B | ||
| -0.03% | +1.62% | +25.62% | +68.30% | 199B | ||
| -0.40% | +7.50% | +21.51% | +82.50% | 169B | ||
| Average | -0.82% | +1.97% | +32.62% | +60.81% | 370.97B | |
| Weighted average by Cap. | -0.38% | +2.13% | +42.26% | +86.55% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 91.56B 958M 839M 775M 715M 1.36B 1.38B 9.28B 3.61B 44.89B 3.6B 3.52B 156B | 104B 1.09B 956M 883M 816M 1.55B 1.58B 10.58B 4.12B 51.19B 4.1B 4.01B 178B |
| Net income | 9.81B 103M 89.86M 83M 76.65M 145M 148M 994M 387M 4.81B 386M 377M 16.69B | 11.5B 120M 105M 97.25M 89.82M 170M 174M 1.17B 453M 5.64B 452M 442M 19.56B |
| Net Debt | 6.75B 70.64M 61.82M 57.1M 52.73M 100M 102M 684M 266M 3.31B 265M 259M 11.48B | 4.56B 47.77M 41.81M 38.62M 35.66M 67.68M 68.94M 463M 180M 2.24B 179M 175M 7.77B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-08 | ₹1,809.30 | -1.86% | 130,096 |
| 26-07-07 | ₹1,843.50 | +0.46% | 124,180 |
| 26-07-06 | ₹1,835.00 | -0.22% | 121,333 |
| 26-07-03 | ₹1,839.10 | -0.94% | 69,426 |
| 26-07-02 | ₹1,856.50 | +1.40% | 183,639 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions


















